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We analyzed the transcriptional profiles of differentiating mouse embryonic stem cells (mESCs) and show that embryoid bodies (EBs)
sequentially expressed genes associated with the epiblast, primitive streak, mesoderm and endoderm of the developing embryo, validating ESCs as
a model system for identifying cohorts of genes marking specific stages of embryogenesis. By comparing the transcriptional profiles of
undifferentiated ESCs to those of their differentiated progeny, we identified 503 mESC and 983 hESC genes selectively expressed in
undifferentiated ES cells. Over 75% of the mESC genes were expressed in hESC and vice versa, attesting to the underlying similarity of mESCs
and hESCs. The expression of a cohort of 68 genes decreased greater than 2-fold during differentiation in both mESCs and hESCs. As well as
containing many validated ESC genes such as Oct4 [Pou5f1], Nanog and Nodal, this cohort included an uncharacterised gene (FLJ30046), which
we designated SLAIN1/Slain1. Slain1 was expressed at the stem cell and epiblast stages of ESC differentiation and in the epiblast, nervous system,
tailbud and somites of the developing mouse embryo. SLAIN1 and its more widely expressed homologue SLAIN2 comprise a new family of
structurally unique genes conserved throughout vertebrate evolution.
© 2006 Elsevier Inc. All rights reserved.Keywords: Embryonic stem cell; Cell differentiation; Transcriptional profiling; SLAIN1Introduction
Embryonic stem cell lines established from the inner cell
mass of preimplantation blastocysts can differentiate into
ectoderm, mesoderm and endoderm (Keller, 1995; Reubinoff
et al., 2000; Thomson et al., 1998), providing an opportunity to
study early stages of mammalian development in vitro.
Characterising the genes that regulate the stem cell state in
both mESCs and hESCs will facilitate the maintenance of
undifferentiated ESCs and their directed differentiation to
clinically relevant lineages for cell replacement therapies of
the future.
Several studies have addressed the hypothesis that stem cells
isolated from different sources might express a conserved
cohort of ‘stemness’ genes. Although two separate reports⁎ Corresponding author. Fax: +61 3 9905 0780.
E-mail address: andrew.elefanty@med.monash.edu.au (A.G. Elefanty).
0012-1606/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2006.01.023comparing the gene expression profiles of mESCs, neural stem
cells (NSCs) and haematopoietic stem cells (HSCs) identified
216 and 283 genes, respectively, only 6 genes were common to
both lists (Evsikov and Solter, 2003; Ivanova et al., 2002;
Ramalho-Santos et al., 2002). When these data were compared
with a subsequent study that identified 385 genes enriched in
populations of ESCs, NSCs and retinal stem cells, only one
gene was common to the three lists (Fortunel et al., 2003).
These findings prompted the authors to question the concept
that a universal set of ‘stemness’ genes accounted for the
properties of self-renewal and multipotency common to stem
cells from different sources (Fortunel et al., 2003).
In an attempt to identify genes specific to ESCs, the
transcriptional profiles of ESCs were compared to a variety of
non-stem cell sources including tumor samples, normal tissues
and cell lines. In this manner, anywhere from 124 to 1760
cDNAs more highly expressed in ESCs were identified
(Richards et al., 2004; Sperger et al., 2003; Tanaka et al.,
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from undifferentiated and differentiated hESCs were compared,
Brandenberger et al. derived a list of 532 genes that were
increased in undifferentiated cells (Brandenberger et al.,
2004b). Highlighting the variability between published results,
only 9 of this list of 532 genes were common with the
‘stemness’ genes generated in the study of Ramalho-Santos et
al. and only 32 with the ‘signature’ genes of Ivanova et al.
(Ivanova et al., 2002; Ramalho-Santos et al., 2002).
When Bhattacharya and colleagues compared sets of genes
enriched in mESCs and hESCs, they found that less than 30% of
their 92 hESC ‘stemness’ genes were represented in published
lists of mESCs genes (Bhattacharya et al., 2004; Ivanova et al.,
2002; Ramalho-Santos et al., 2002; Tanaka et al., 2002).
Similarly, a study by Sato et al. compared 918 genes enriched in
undifferentiated H1 hESC to published mESC-derived data
(Ramalho-Santos et al., 2002) and found that 227/541 (42%) of
the genes with mouse orthologues were highly enriched in
mESCs, also indicating a limited overlap in the gene expression
profiles of hESC and mESC (Sato et al., 2003).
In this study, we analyzed the transcriptional profiles of
differentiating mESCs and demonstrate the sequential expres-
sion of genes associated with embryonic epiblast, primitive
streak, mesoderm and endoderm, consistent with the hypothesis
that in vitro differentiation of ESCs recapitulates molecular
changes associated with normal embryonic development. These
data provided a rational framework for our prediction that the
expression of genes specific to undifferentiated mESC would
decrease by day 4 of differentiation, the time when germ layer
genes were activated. Using this criterion, a list of 503 putative
mESC stem cell genes was identified and similar transcriptional
profiling of undifferentiated and differentiated hESCs led to the
identification of an analogous population of 983 hESC putative
stem cell genes. Attesting to the underlying similarity of mESCs
and hESCs, greater than 75% of the mESC stem cell genes were
expressed in undifferentiated hESCs and vice versa. A cohort of
68 of these genes, whose transcription decreased greater that 2-
fold during differentiation of both mESCs and hESCs, included
many previously validated ESC stem cell genes as well as a
novel gene, designated SLAIN1 (FLJ30046). In this report, we
show that SLAIN1 is expressed at the stem cell and epiblast
stages of ESC differentiation and in the epiblast, nervous
system, tailbud and somites of the developing mouse embryo.
SLAIN1 and its more widely expressed homologue SLAIN2
form a new family of structurally unique vertebrate genes.
Materials and methods
Culture and differentiation of mESCs and hESCs
W9.5 ES cells were cultured as previously described (Barnett and Kontgen,
2001). The Slain1-βgeo gene trapped mESC lines (XG385, XG752 and
XH855) were obtained from the NIH sponsored NHLBI-BayGenomics (http://
baygenomics.ucsf.edu/overview/projorg.html) and NCRR-Mutant Mouse Re-
gional Resource Center (http://www.mmrrc.org/). The Slain1-βgeo ES cell lines
were cultured under antibiotic selection (150 μg/ml Geneticin) in Knockout™
DMEM supplemented with 15% Knockout™ Serum Replacement, non-
essential amino acids, 2 mM Glutamine, 50 units/ml Penicillin, 50 μg/ml
Streptomycin (all from Invitrogen), 50 mM 2-mercaptoethanol (Sigma), and1000 units/ml LIF (Chemicon). Both the W9.5 and the Slain1-βgeo ES cell lines
were differentiated as described (Ng et al., 2005a). Briefly, mESCs were seeded
at 5000 cells/ml in Differentiation Media comprising Iscove's Modified
Dulbecco's Medium (Invitrogen) supplemented with 15% FCS in non-adherent
dishes for the indicated number of days. Alternatively, cells were differentiated
under serum-free conditions in Chemically Defined Medium (Wiles and
Johansson, 1999) modified as described (Ng et al., 2005a) in the presence or
absence of 10 ng/ml of BMP4 (R&D Systems). The hES2 cell line was
maintained on monolayers of irradiated PMEFs as previously described
(Reubinoff et al., 2000). hESC differentiation was induced by embryoid body
formation in hanging drops in Differentiation Media for 5 days. Embryoid
bodies were then plated on gelatin-coated dishes for a further 9 days to allow
further differentiation and expansion.
Flow cytometry
Embryoid bodies were dissociated using trypsin/EDTA (Invitrogen)
supplemented with 1% chicken serum (Hunter). FACS-Gal analysis was
performed as described (Elefanty et al., 1999; Fiering et al., 1991). In some
experiments, dissociated cells were stained with antibodies directed against Flk-
1 (directly conjugated to PE: BD Biosciences) or E-cadherin (Zymed) detected
with allophycocyanin-conjugated goat anti-rat IgG (BD Biosciences) prior to
FACS-Gal analysis. Cells were analyzed using a FACSCalibur running
CellQuest software (Becton Dickinson).
GeneChip sample preparation and hybridisation
Biotin-labelled cRNA was prepared essentially as specified by the
Affymetrix standard protocol. Briefly, total RNA was isolated from cells using
QIAShredder and RNeasy mini columns including an in-column DNase I
digestion (Qiagen). cDNAwas synthesized from 7.5 μg of total RNA using an
oligo dT(24) primer containing a T7 RNA polymerase binding site. Biotinylated
cRNA was produced using the BioArray High-Yield Transcript Labeling Kit
(Enzo Diagnostics). Fifteen micrograms of labelled cRNA was fragmented for
35 min at 94°C in fragmentation buffer before hybridisation. Hybridisation and
washing were performed according to Affymetrix recommended protocols.
Data analysis
Raw data analysis
Scanned GeneChip images were analyzed using MicroArray Suite 5.0 and
additional analysis performed using Data Mining Tool 3.0 (Affymetrix).
Microarray data are available at the ArrayExpress web site (http://www.ebi.ac.
uk/arrayexpress/) via Accession numbers E-MEXP-303 and E-MEXP-304.
Identification of differentially expressed genes
Duplicate samples of undifferentiated mESCs and d4 mEBs from two
independent differentiations were analyzed by pairwise comparisons. Samples
of undifferentiated hES2 cells (from passage 19 and 128) were compared to EBs
differentiated for 5 days (d5 hEBs) in hanging drops or d5 hEBs that were plated
onto gelatin for further 9 days (d14 hEBs). ESCGs were characterised by the
following criteria: (1) they were present in both baseline samples, (2) they were
decreased in at least 3 of the 4 pairwise comparisons between undifferentiated
and differentiated samples, and (3) there was at least a 2-fold decrease in 2 of the
4 pairwise comparisons.
Comparison of human and mouse enriched genes
Orthologues for ESCGs located on either the Human HG-U133A and B or
mouse MG-U74Av2 GeneChips were identified using a combination of the
NetAffx website (http://www.netaffx.com) and BLASTn searches (http://www.
ncbi.nlm.nih.gov/BLAST/).
Expression analysis
Total RNA was extracted from adult mouse organs using the RNeasy Midi
Kit according to the manufacturer's instructions (Qiagen). A multi-tissue RNA
Northern blot containing 10 μg of total RNA for each tissue was probed with a
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4 to 9 of mouse Slain1. Semi-quantitative RT-PCR was performed as previously
described (Elefanty et al., 1997). Thirty cycles of amplification were used for all
the primer sequences at the annealing temperatures shown in Supplementary
Table 4.
Whole mount in situ hybridisation
A probe coding for nucleotides 894 to 1848 of the mouse Slain1 cDNA
(accession number BC079866) was cloned into pBluescriptKS. Whole mount in
situ hybridisation was performed using in vitro transcribed, digoxygenin-
labelled cRNA essentially as described previously (Pera and Kessel, 1997).Results
Differentiating mouse ES cells sequentially express
developmental stage-specific genes
In order to document the repertoire of genes expressed in
ESC and their differentiated progeny, we analyzed the
transcriptional profiles of mESCs at daily intervals over 6
days of differentiation using the murine U74Av2 Affymetrix
GeneChip. The microarray data were validated by semi-
quantitative RT-PCR analysis of selected genes that marked
sequential developmental stages in the embryo, including inner
cell mass (Oct4 [Pou5f1], Rex1 [Zfp42], and Gbx2), epiblast
(Fgf5), primitive streak (Brachyury [T]), and haematopoietic
mesoderm (Flk1 [Kdr] and βH1 globin [Hbb-b1]) (Supplemen-
tary Fig. 1). These data correlated well with previously reported
patterns of gene expression during ES cell differentiation
(Keller et al., 1993; Lacaud et al., 2002; Ng et al., 2005a;
Robertson et al., 2000).
GeneChip analysis revealed the concerted expression of
differentiation stage-specific genes in a series of distinct
‘waves’ (Fig. 1). The ‘signature’ genes that have been chosen
to demonstrate this phenomenon have been shown by others to
be expressed at the appropriate stages in embryonic develop-
ment, thus establishing a link between the data generated from
in vitro ES differentiation and the embryo. The expression of
most validated stem cell genes such as Oct4, FoxD3, Rex1,
Gbx2, and Sox2 was high in undifferentiated mESCs and had
waned significantly by d4 of differentiation consistent with their
expression in the early embryo (see examples in Pelton et al.,
2002) (Fig. 1A). The biphasic expression of Nanog, with peaks
of expression at d0 and at d3 of differentiation, mirrored its
distribution in vivo in the inner cell mass of the preimplantation
blastocyst and later in the epiblast adjacent to the elongating
primitive streak (Hart et al., 2004). The second wave of genes
that peaked in expression at d2–3 included the epiblast markerFig. 1. Sequential expression of genes during mESC differentiation reflects
successive stages of embryological development. Relative transcript level for
sets of genes indicative of the developmental stages representing (A) stem cells,
(B) epiblast, (C) primitive streak, (D) ventral mesoderm, and (E) endoderm.
Relative transcript levels represent the signal strength for each transcript
expressed as a percentage of the maximal signal for that gene. (F) Expression
profile of single genes representing each of the developmental stages shown in
panels A–E demonstrating that the temporal relationship between each stage of
ESC differentiation mirrors the sequential phases of embryonic development.
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al., 2002) and a number of genes including Retinoid X receptor
gamma (Rxrg), Occludin (Ocln), and Claudin 6 and 7 (Cldn6
and 7) (Fig. 1B), which have been associated with epithelial-
ization (Kubota et al., 2001; Turksen and Troy, 2001). At d3–4,
we identified a third stage of differentiation that was
characterised by a rapid, transient increase in transcription of
the primitive streak markers such as Brachyury, Eomesodermin
[Eomes], Wnt3, and Fgf8 (see examples in Ciruna and Rossant,
1999; Liu et al., 1999) (Fig. 1C). Consistent with the fact that
haematopoietic and endothelial cells are the first mesodermal
lineages to emerge from the primitive streak (Kinder et al.,
1999), we noted an upregulation in the expression of genes
marking ventral mesoderm including Flk1, Gata1-3, Runx1, Scl
[Tal1], and βH1 globin in d5 and d6 EBs (see examples in
Elefanty et al., 1999; Levanon et al., 2001; Yamaguchi et al.,
1993) (Fig. 1D and data not shown). Endodermal genes such as
Gata6, Sparc, Keratin 19 (Krtl-19), and Collagen type IV, alpha
5 (Col4a5) were also expressed at this stage (see examples in
Holland et al., 1987; Morrisey et al., 1996; Tamai et al., 2000)
(Fig. 1E). However, it was not possible to unambiguously
classify the type of endoderm formed because many of these
genes are expressed in both primitive and in definitive
endodermal lineages. The sequential overlapping nature of the
differentiation stages was evident when the expression levels for
individual genes representing examples of each developmental
stage were superimposed on the same graph (Fig. 1F).
Stem cell genes are conserved in mouse and human ESCs
Examination of global changes in gene transcription during
mESC differentiation indicated that extensive changes in gene
expression accompanied the establishment of germ layers.
Specifically, 723 probe sets decreased and 704 probe sets
increased more than 2-fold when d0 and d4 samples were
compared in one experiment (Fig. 2). Because most of the
validated stem cell genes (Fig. 1A) were significantly down-Fig. 2. Extensive changes in gene expression accompanied the establishment of germ
probes sets at each day of differentiation whose signal had increased (□) or decreas
change in number of probe sets that conformed to the above criteria occurred between
equivalent of gastrulation.regulated during this interval, we hypothesized that stem cell
genes could be operationally defined as genes expressed in
undifferentiated ES cells whose transcription decreased in their
differentiated progeny.
Therefore, we nominated genes whose expression fell by
greater than 2-fold between d0 and d4 as embryonic stem cell
genes (ESCGs) (see Materials and methods). Of the 503 genes
that fulfilled this criterion, 436 (86.7%) represented named
genes while the remaining 67 (13.3%) comprised ESTs, RIKEN
clones, and other uncharacterised transcripts (Fig. 3A). We
hypothesized that human orthologues of mESCGs should also
be expressed in hESCs and should also decrease during hESC
differentiation. Orthologues represented on the HG-U133 A and
B chips were identified for 89.3% (449) of the mESCGs,
comprising 94.5% (412/436) of the named genes and 55.2% (37/
67) of the ESTs/RIKEN clones. Of these human orthologues,
75.9% (341/449) were expressed in undifferentiated hESCs,
testifying to the underlying similarity of ESCs in the two species
(Fig. 3A). Expression of 34.3% (117/341) genes decreased
during differentiation, although the signal intensity decreased
less than 2-fold in most cases. The signal of an additional 43.4%
(148/341) genes remained stable, and the expression of 22.3%
(76/341) genes increased (Fig. 3A and Supplementary Table 1).
A complementary experiment in which the transcriptional
profiles of undifferentiated hESCs were compared with their
differentiated counterparts identified 983 hESCGs that de-
creased by greater than 2-fold with differentiation (Fig. 3B).
52.6% (517/983) of the hESCGs had mouse orthologues
represented on the MG-U74Av2 chip, and of these orthologues,
79.9% (413/517) were expressed in undifferentiated mESCs
(Fig. 3B). Similar to our observations with the mESCGs, 37.3%
(154/413) of the hESCGs decreased to some degree during
mESC differentiation whilst the remainder either remained
unchanged (35.1%, 145/413) or increased (27.6%, 114/413)
(Fig. 3B and Supplementary Table 2).
Combining the 117 mESCGs with human orthologues whose
expression decreased during hESC differentiation (Fig. 3A)layers. Graph of global changes in gene expression showing the total number o
ed (▪) greater than 2-fold when compared to d0 mESCs. The greatest rate oday 3 and 4 which corresponds to a time when cells are undergoing the moleculaf
f
r
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of 203 genes specific to undifferentiated ESCs (udESCGs) (Fig.
4A). Sixty-eight of these genes (58% of the mESCGs)
decreased more than 2-fold with differentiation in both species
whilst 86 hESCGs and 49 mESCGs downregulated by lesser
amounts in both differentiated mouse and human ESCs,
respectively (Fig. 4B and Supplementary Table 3). This ‘core
group’ of 68 genes included many with validated roles in
maintaining the stem cell properties of ESCs such as Oct4,
Rex1, Foxd3, Nanog, and Sox2, as well as other genes that play
important roles in early embryonic development such as Gdf3,
Nodal, Phc1, and Utf1. Classification of the remaining human
and mouse ESCGs revealed that these represented intracellular
signalling molecules, metabolic enzymes, transcription factors,
and secreted factors (Fig. 4B).
The 68 core ESCGs also included three incompletely
characterised transcripts encoding hypothetical protein
FLJ30046, HCV F-transactivated protein 1, and developmental
pluripotency associated 4 (Dppa4). Dppa4 has recently been
described as a gene with a similar transcriptional profile to
Oct4 (Bortvin et al., 2003) and, along with its human
orthologue hypothetical protein FLJ10713, has been identified
as an ESC gene in several recent transcriptional profiling
experiments (Brandenberger et al., 2004a; Rao et al., 2004;
Richards et al., 2004; Sato et al., 2003; Sperger et al., 2003).
However, the other genes, FLJ30046 (with its respective
mouse orthologue 9630044O09Rik) and LOC401152 (also
known as HCV F-transactivated protein 1 and its mouse
orthologue 1810037I17Rik), have not been previously identi-
fied as potential stem-cell-specific genes. We have focussed on
FLJ30046 and its mouse orthologue 9630044O09Rik, which
we designated SLAIN1 due to the presence of a C-terminal
‘SLAIN’ amino acid motif.
SLAIN1 and SLAIN2 encode related genes conserved in
vertebrates
Examination of public sequence databases revealed that
SLAIN1 was well conserved in vertebrates, with ESTs from
mouse and human 84.8% identical at the nucleotide level.
Homologues of SLAIN1 were identified in rat, chicken, cow,
pig, frog, and zebrafish (Fig. 4A and Supplementary Fig. 2). A
second highly related cluster of transcripts including
5033405K12Rik and KIAA1458 in mouse and humans,
respectively, were also identified and designated as SLAIN2
(Supplementary Fig. 3). This gene was also highly conserved in
vertebrates, suggesting that SLAIN1 and SLAIN2 represented
two members of a novel gene family (Fig. 5A).
The 8 exons of the mouse Slain1 gene spanned approxi-
mately 55 kb of mouse chromosome 14 (Fig. 6). Sequence
analysis of ESTs derived from mouse Slain1 mRNA indicatedFig. 3. Identification of embryonic stem cell genes (ESCGs) during differentiation of
were identified based on their expression in undifferentiated cells and downregulation
mouse GeneChips were identified and expression in undifferentiated and differentiat
expressed in hESCs and decreased with hESC differentiation and mouse ortholo
differentiation. See text for further details.the presence of a splice variant in which exon 3 was omitted,
resulting in a 50 amino acid internal deletion that did not alter
the reading frame. This variable splicing was confirmed by RT-
PCR analysis of cDNA from mouse ESCs and adult mouse
brain, from which both longer and shorter products were
obtained (data not shown).
The shorter human SLAIN1 ESTs corresponded to exons 4 to
8 of the mouse Slain1 gene and mapped to human chromosome
13 in the region syntenic to mouse chromosome 14. Three
upstream human SLAIN1 exons were predicted, based on the
high degree of similarity between the human and the mouse
Slain1 loci, resulting in a complete human SLAIN1 gene also
consisting of 8 exons spanning 65 kb of genomic sequence. The
sizes of both exons and introns were well conserved between
the two species, and all intron–exon boundaries conformed to
the AG/GT rule (Fig. 6). A similar genomic organization of
human and mouse SLAIN2 genes was observed, with homo-
logues in both species consisting of 8 exons of a similar size and
distribution to those found in SLAIN1. The SLAIN2 genes
spanned 75 kb of human chromosome 4 and 60 kb of the
syntenic region of mouse chromosome 5 (Fig. 6). The high
degree of similarity in the nucleotide sequence and genetic
structure suggests that SLAIN1 and 2 are members of the same
gene family.
Conceptual translations of the open reading frames of mouse
Slain1 mRNA and the putative full-length transcript of human
SLAIN1 predicted proteins of 629 and 640 amino acids,
respectively, with 86.3% identity (Fig. 5B). Mouse and
human SLAIN2 proteins both predicted to encode proteins of
581 amino acids, were 93.8% identical, and were 37.1% and
36.3% identical to their respective SLAIN1 homologues (Fig.
5B). Analysis of the protein sequence using MotifScan (http://
myhits.isb-sib.ch/cgi-bin/motif_scan) indicated the presence of
serine-rich domains in both SLAIN1 and SLAIN2, while
SLAIN1 also contained an N-terminal proline-rich domain (Fig.
5B). While proline- and serine-rich domains can mediate
protein–protein interactions, at this stage, their functional
importance in SLAIN1 and 2 is speculative.
SLAIN1 is expressed at the ‘epiblast’ stage of ESC
differentiation prior to gastrulation and in the embryonic
epiblast and nervous system
RT-PCR analysis of Slain1 expression in differentiating
mESCs revealed maximal Slain1 mRNA levels on d2, which
declined by d6 of mESC differentiation. Similarly, in hESC
differentiation, robust expression of SLAIN1 mRNA was
observed in undifferentiated hESCs, which also waned during
hESC differentiation. These RT-PCR results were consistent
with the relative transcript levels observed in the microarray
data (Figs. 7A, B). Slain1 was also detected in adult thymus,(A) mouse and (B) human ES cells. 503 mouse ESCGs and 983 human ESCGs
by at least 2-fold in differentiated progeny. Orthologues of ESCGs on human and
ed cells evaluated. By these analyses, human orthologues of 117 mESCGs were
gues of 154 hESCGs were expressed in mESCs and decreased with mESC
Fig. 4. Embryonic stem cell genes shared between mouse and human ESCs. (A) Summary of the filters used to identify the mouse and human ESCGs described in Figs.
3A and B. The primary filter (1°) identified genes expressed (P) in undifferentiated ESCs (U) that decreased at least 2-fold (dec) in differentiated cells (D). The
secondary filter (2°) identified orthologues for these genes in the reciprocal species that were present in undifferentiated cells and downregulated (lo) during
differentiation. (B) Venn diagram demonstrating the overlap between the 117 mouse (blue) and 154 human ESCGs (red), demonstrating that 203 genes are enriched in
undifferentiated ESCs (udESC genes). This includes 68 genes that were downregulated 2-fold in both mouse and human ESCs (core ESCGs) with 49 and 86 genes that
were downregulated to a lesser extent in mouse and human ESCs, respectively. These genes were classified by their GO Biological Process descriptions.
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Fig. 5. High degree of homology between mammalian Slain1 and Slain2 orthologues. (A) Dendrogram of mammalian Slain1 and Slain2 genes. Consensus nucleotide
sequences fromHomo sapiens (Hs),Mus musculus (Mm), Rattus norvegicus (Rn), Bos taurus (Bt), and Sus scrofa (Ss) were aligned and the phylogenetic tree drawn in
MegAlign 6.00 (DNASTAR). (B) Slain1 and Slain2 proteins from mouse (Mm) and human (Hs) were aligned using the Clustal W method in MegAlign 6.00
(DNASTAR). Amino acids identical to mouse Slain1 are indicated by white lettering on a black background. An asterisk indicates the SLAIN motif.
Fig. 6. Slain1 and Slain2 gene loci share a conserved intron–exon structure. Nucleotide sequences of human (h) and mouse (m) Slain1 and Slain2 transcripts were
aligned to corresponding genomic sequences using MegaBLAST (http://www.ncbi.nlm.nih.gov/blast/megablast.shtml) and intron–exon boundaries confirmed using
Spidey (http://www.ncbi.nlm.nih.gov/IEB/Research/Ostell/Spidey). Exon sizes (in nucleotides) are indicated within each box, and approximate intron sizes (in kb) are
shown between boxes.
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and kidney by RT-PCR (Figs. 7C and D). RT-PCR analysis of
Slain2 mRNA indicated that it was not expressed in a restricted
manner (data not shown) and has not been investigated further.We identified three mESC lines generated in the BayQ
Genomics Project (http://baygenomics.ucsf.edu/overview/projorg.
html) in which gene trap vectors had integrated into the mouse
Slain1 locus. Three clones (XG385, XG752, and XH855) that
contained a βgeo fusion gene inserted into intron B of Slain1 (as
illustrated Fig. 8A) were obtained from the Mutant Mouse
Regional Resource Center (http://www.mmrrc.org/). Flow
cytometry was used to determine the percentage of viable
cells expressing βgalactosidase (βgal) from the Slain1 locus
during mESC differentiation using the FACS-Gal technique
(Fiering et al., 1991). Consistent with the RT-PCR analysis of
Slain1 transcription (Fig. 7A), approximately 20% of undiffer-
entiated mESCs expressed Slain1-βgal, and this increased to
include over 80% of cells at d3 of differentiation, with the slight
delay in the peak in Slain1-βgal expression as compared to the
peak in Slain1 mRNA at d2, reflecting the longer processing
time required for expression of the βgal protein (Fig. 8B). The
proportion of βgal-expressing cells diminished rapidly thereaf-
ter. A similar expression profile was observed for each of the
three Slain1-βgal ESC lines (Fig. 8C).
Based on our transcriptional profiling data (Fig. 1B), the
pattern of Slain1 mRNA expression suggested that it repre-
sented an ‘epiblast stage’ gene. One prediction of this
hypothesis was that Slain1 mRNA would be co-expressed
with E-cadherin, a marker of stem cells, epiblast, and primitive
streak (Burdsal et al., 1993; Ciruna and Rossant, 2001; Ng et al.,
2005a). Indeed, all βgal-expressing cells at d3 co-expressed E-
cadherin (Fig. 8D). By d4, some βgal-expressing cells were E-
cadherin−, either indicating that Slain1 transcription persisted in
some epiblast or primitive streak derivatives or reflecting the
long half-life of the βgeo reporter gene (Fig. 8D). Analysis of
the same cells for expression of the ventral mesoderm marker
Flk1 revealed that most Flk1+ cells did not express βgal,
indicating that Slain1 was not significantly expressed in ventral
mesoderm.
In previous studies, it had been observed that mESCs
differentiated in serum-free (SF) media defaulted to neurecto-
dermal differentiation and supplementation of the medium with
bone morphogenetic protein (BMP) 4 induced expression of
primitive streak markers and ventrally patterned mesoderm,
leading to blood cell formation (Ng et al., 2005a; Park et al.,
2004; Wiles and Johansson, 1999). Therefore, we investigated
the expression of βgal in Slain1-βgal ESCs differentiated in SF
medium in the absence and presence of BMP4 (Fig. 8E). In the
presence of BMP4, a similar profile of βgal expression was
observed as in serum-containing cultures, with over 80% of
cells expressing βgal at d3 and fewer than 10% βgal-positive by
d6. In Slain1-βgal ESCs differentiated in the absence of BMP4,Fig. 7. Slain1 is expressed during ESC differentiation and in selected adult
tissues. (A and B) RT-PCR analysis of Slain1 expression during ESC
differentiation indicates that Slain1 expression (A) peaked at d2 and d3 of
mESC differentiation and (B) was robustly expressed in undifferentiated hESCs,
correlating with the relative transcript levels calculated from GeneChip signals
for human and mouse Slain1 probe sets. (C and D) Tissue distribution of mouse
Slain1mRNA. (C) Semi-quantitative RT-PCR analysis of Slain1mRNA in adult
mouse tissues compared to HPRT expression. (D) Northern blot analysis of
Slain1mRNA in adult mouse tissues with 28S and 18S RNA as loading control.
Fig. 8. Expression of Slain1 during mESC differentiation. (A) Cartoon of mouse Slain1 gene structure indicating the insertion site of the En2 βgeo cassette in intron B.
(B) Time course of βgalactosidase expression in differentiating XG385 Slain1-βgeo gene trapped ESCs as determined by FACS-Gal. The percentage of βgal-positive
cells is shown in the lower right of each plot. (C) Graph showing the percentage (mean ± SD) of βgal-positive cells for all three Slain1-βgeo ESC lines throughout
differentiation. (D) Correlation of E-cadherin and Flk-1 with βgal expression in differentiating Slain1-βgeo ESCs. (E) Differentiation of Slain1-βgeo ESCs in serum-
free (SF) media supplemented with (+) or without (−) BMP4.
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even at d6. Most of these cells no longer expressed E-cadherin
(data not shown), suggesting that the βgal-positive cells were
no longer at the epiblast stage and that Slain1 expression
continued in primitive neurectodermal cells. Consistent with
these predictions, whole mount in situ hybridisation of post-
implantation mouse embryos demonstrated widespread expres-
sion of Slain1 throughout the E6.5–E7.0 embryo (Figs. 9A–D)
that was followed by higher levels of expression in the headfold
neurectoderm at E7.5 (Figs. 9E, F). As embryonic development
continued, Slain1 mRNA was observed in the neural tube and
optic vesicles at E8.5 and then at sites of imminent neural tube
closure in the midbrain, hindbrain, and tailbud at E9.0–E9.5 and
in the dorsal aspects of the somites (Figs. 9G–L).Discussion
We have utilised transcriptional profiling to demonstrate the
sequential expression of genes representing stem cell, epiblast,
primitive streak, and germ layer stages of development in
differentiating mESCs. These data extend prior observations
that ESC differentiation represents a valid facsimile for early
post-implantation mammalian embryogenesis by providing
expression data for a larger number of stage-specific genes
than previous studies have examined (Doetschman et al., 1985;
Keller et al., 1993; Leahy et al., 1999; Palmqvist et al., 2005;
Schmitt et al., 1991; Shen and Leder, 1992; Wiles and
Johansson, 1999; Wiles and Keller, 1991). The concordance
between the stage-specific expression of genes observed during
Fig. 9. Slain1 is expressed throughout the E6.5–E7 embryo and subsequently in the neural tube, tailbud, and somites of the post-implantation mouse embryo at
E8.5–E9.5. Whole mount in situ hybridisation of mouse embryos hybridised with sense (A, E, G) or anti-sense (B–D, F, H–L) Slain1 probes corresponding to
bases 894 to 1848 of the mouse Slain1 cDNA (accession number BC079866). At E6.5, Slain1 is expressed throughout the embryo (A–D), at E7.5, there is
enhanced expression in the headfolds (E, F), and from E8.5 to E9.5, in the optic vesicle (ov), neural tube (nt), midbrain (mb), hindbrain (hb), tailbud (tb) and the
dorsal aspects of the somites (so).
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suggests that the mechanisms that regulate and coordinate these
processes in vivo are, to a significant degree, operational in
vitro. This is an important validation of the ES differentiation
system and gives confidence that the in vitro differentiation
process is predictable and that findings in vitro are relevant to
the intact organism.
Our analysis indicated that, by d4 of ES differentiation,
substantial changes in the repertoire of expressed genes had
occurred, including the downregulation of known stem cell
genes (see Figs. 1 and 2). This information was used to devise
an operational definition for ESC genes, using the criteria of
expression in undifferentiated ESCs followed by downregula-
tion by the time of germ layer formation. In order to more
stringently define genes likely to be of broad functional
importance in ESCs, we narrowed the inclusion criteria to
only include those mESC genes with human orthologues that
were also restricted in expression to undifferentiated hESCs and
vice versa. This defined a group of 203 genes enriched in
undifferentiated ESC genes (udESCGs) that were downregu-
lated 2-fold during differentiation in one species and also
downregulated to some degree in the other (117 from mESCsand 154 from hESCs). This included a core group of 68 ESCGs
that demonstrated a greater than 2-fold reduction in expression
during both mouse and human ESC differentiations.
A number of different studies have attempted to identify
genes whose expression defines the stem cell state (Abeyta et
al., 2004; Bhattacharya et al., 2004; Brandenberger et al.,
2004b; Fortunel et al., 2003; Ivanova et al., 2002; Ramalho-
Santos et al., 2002; Rao et al., 2004; Richards et al., 2004; Sato
et al., 2003; Sperger et al., 2003; Tanaka et al., 2002). However,
the lists of postulated stem cell genes generated in different
studies contained few members in common (Palmqvist et al.,
2005). Therefore, it was not surprising that the 283 ‘signature’
genes described by Ivanova et al. included only 5 of our 203
udESCGs, that only 8 were incorporated in the 216 ‘stemness’
genes of Ramalho-Santos et al., and that no genes were shared
between all three studies (Ivanova et al., 2002; Ramalho-Santos
et al., 2002). Furthermore, only 3 of the ‘signature’ genes
described by Ivanova et al. and none of the ‘stemness’ genes of
Ramalho-Santos et al. were included in our 68 core ESCGs. The
discrepancies between these gene lists could be contributed to
by the multiplicity of tissues compared in some studies,
variations in the purity of the stem cell populations analyzed,
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similar functions in different stem cell populations (Burdon et
al., 2002; Fortunel et al., 2003; Ivanova et al., 2003). However,
an equally plausible conclusion from these studies is that there
is no common set of genes whose expression defines stem cell
characteristics for all tissue types.
We observed the greatest similarity between our data and that
reported by Palmqvist et al., who examined transcriptional
changes occurring during the first 72 h of mESCs differentiation
(Palmqvist et al., 2005). Comparison of our 503 mESCGs with
their 187 genes ‘decreased after 72 h of LIF removal’ indicated
that nearly 50% (93/187) of these genes were included in our
data set. Surprisingly, only 14 genes were shared with our 68
core ESCGs. This reduced overlap was in part due to the fact
that the study of Palmqvist et al. omitted a number of well-
characterised ESC genes such as Oct4, Nanog, and FoxD3 that
were downregulated more slowly and thus were missed by their
use of a 72 h endpoint (see Fig. 1).
However, comparisons of the results of other studies that
searched for genes specifically expressed in ESCs revealed a
low degree of overlap. Therefore, it was not surprising that
only 3/25 ‘most positively significant genes’ in hESC reported
by Sperger et al., 6/66 ‘candidate hESC signature genes’ from
Golan-Mashiach et al., 4/92 genes ‘common to 6 hESC lines’
identified by Bhattacharya et al., 11/227 ‘genes enriched in
both hESCs and mESCs’ from Sato et al., and 11/133
‘pluripotent specific genes’ described by Rao and colleagues
were included in our list of 68 core ESCGs (Bhattacharya et
al., 2004; Golan-Mashiach et al., 2005; Sperger et al., 2003). It
transpired that Oct4 was the only gene identified by all of these
comparisons.
It is notable that our study was the only one that directly
compared mouse and human ES cells using material cultured,
harvested, and processed in the same laboratory, assayed on the
same platform type, and analyzed using the same data analysis
software. As highlighted in recent literature, variability in the
microarray platform, labelling and hybridisation protocols, and
data analysis software contributed significantly to the lack of
concordance observed between different groups' comparisons
of similar samples (Bammler et al., 2005; Irizarry et al., 2005;
Larkin et al., 2005). It is reasonable to suggest that these
problems contributed to the disparity between data sets reported
in other stem-cell-related gene profiling studies. In this context,
it is relevant that we observed a greater than 75% concordance
between the genes expressed in mESCs and hESCs, indicating
that ESCs from these two species may indeed be more similar
than other studies have suggested (Bhattacharya et al., 2004;
Ginis et al., 2004; Sato et al., 2003).
Furthermore, our list of genes included most of the
recognized ESC genes including FGF4, FoxD3, Nanog,
Nodal, Oct4, Rex1, Sox2, and Utf1 (as reviewed in (Rao,
2004) and also encompassed other genes with predicted roles in
maintaining ESC pluripotency such as SFRP1, a modulator of
Wnt signalling, LeftB, a member of the TGFβ signalling
pathway, and DNMT3a, a gene required for the establishment
and maintenance of methylation patterns in mESCs (Chen et al.,
2003). This is the first study to show that this cohort of stem cellgenes is downregulated in a similar manner during both hESC
and mESC differentiation, consistent with the similar patterns of
in vitro differentiation of mESC and hESC that we have
observed (Ng et al., 2005a, 2005b).
Our core list of 68 ESCGs included three incompletely
characterised transcripts encoding hypothetical protein
FLJ30046, LOC401152 (gene designation HCV F-transacti-
vated protein 1), and developmental pluripotency associated 4
(Dppa4). Dppa4 was recently identified along with Dppa2,
Dppa3 (also known as Stella or PCG7), and Dppa5 (Esg1) in a
screen for genes with similar transcriptional profiles to Oct4
(Bortvin et al., 2003).
In this study, we focussed our analysis on FLJ30046
(9630044O09Rik), a gene that we subsequently designated
SLAIN1 (Slain1). The presence of serine- and proline-rich
domains within the protein sequence suggests that Slain1 may
interact with other proteins, but the nature of these interactions
is not yet clear. In vitro differentiation of Slain1-βgeo gene
trapped mESC lines demonstrated a peak of Slain1 expression
at d2–3 (epiblast stage), in keeping with the microarray and
PCR data. Further analysis of βgalactosidase activity in these
lines indicated that Slain1 expression was downregulated in
Flk-1 expressing ventral mesoderm but persisted in ESCs
differentiating towards neurectodermal in SF medium in the
absence of growth factors. The applicability of these results to
the early mouse embryo was demonstrated by in situ
hybridisation, which demonstrated widespread Slain 1 expres-
sion in the pregastrulation embryo and, subsequently, the
developing nervous system and somites. In the adult, Slain1
mRNAwas found in brain, thymus, testis and lung by Northern
blot and also in bone marrow and kidney by RT-PCR, indicating
that Slain1 expression was not restricted to ectodermal
derivatives.
The localisation of Slain1 to mouse chromosome 14 placed
the gene within the piebald coat colour-spotting locus that
spans an 18 cM interval surrounding the endothelin B receptor
(Ednrb) gene. Deletion complementation analysis has defined
several critical regions in this locus that delineated distinct
phenotypes of respiratory distress syndrome, skeletal patterning
defects and spinal cord malformations (Peterson et al., 2002).
The Slain1 gene appears to lie within a 1.3 cM deletion region
designated as Ednrbs-1Acrg (Welsh and O'Brien, 2000). The
Ednrbs-1Acrg mutant mice exhibited predominantly skeletal
patterning defects with a range of abnormalities including failed
tailbud development, reduced somite numbers, and neural tube
defects including underdeveloped and open neural folds (Welsh
and O'Brien, 2000). The expression of Slain1 in these regions
of the post-gastrulation mouse embryo makes it a possible
candidate for the mutant gene. Targeted mutation of the Slain1
locus in mice is now required to clarify its role as candidate for
this syndrome.
In summary, the inclusion of most of the known ESC genes
in our ‘core’ ESCG set vindicates the strategy taken to identify
stem-cell-enriched genes and supports the comparison of
transcriptional profiles of closely related cell types as a means
of identifying genes that mark different stages of development
or cellular differentiation.
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